1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Toronto Stock Exchange  -  05/18 04:00:00 pm EDT
1.760 CAD   -3.30%
09:12aOpsens Announces Publication of New Optowire Data in Journal
MT
08:48aOpsens announces publication in jscai of data supporting the correlation between the optowire and a novel tavr interface with standard of care, before and after tavr
AQ
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Opsens : Initiated At Outperform By Raymond James

02/01/2021 | 08:24am EDT


ę MT Newswires 2021
All news about OPSENS INC.
09:12aOpsens Announces Publication of New Optowire Data in Journal
MT
08:48aOpsens announces publication in jscai of data supporting the correlation between the op..
AQ
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
04/26Opsens announces health canada approval for its new tavr guidewire
AQ
04/26Opsens Inc. Announces Health Canada Approval for Its New TAVR Guidewire
CI
04/13TRANSCRIPT : Opsens Inc., Q2 2022 Earnings Call, Apr 13, 2022
CI
04/13OPSENS : CEO Certification
PU
04/13OPSENS : CFO Certification
PU
04/13Opsens Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Februa..
CI
04/13OpSens Swings to Loss in Fiscal Q2 as Consolidated Sales Drop
MT
More news
Analyst Recommendations on OPSENS INC.
More recommendations
Financials
Sales 2022 36,6 M 28,5 M 28,5 M
Net income 2022 -7,29 M -5,67 M -5,67 M
Net Debt 2022 - - -
P/E ratio 2022 -26,1x
Yield 2022 -
Capitalization 191 M 148 M 148 M
Capi. / Sales 2022 5,22x
Capi. / Sales 2023 3,51x
Nbr of Employees 163
Free-Float 95,0%
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 1,76 CAD
Average target price 4,22 CAD
Spread / Average Target 140%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.-41.29%154
THERMO FISHER SCIENTIFIC-19.16%217 105
DANAHER CORPORATION-24.33%178 236
INTUITIVE SURGICAL, INC.-37.33%80 830
SIEMENS HEALTHINEERS AG-14.68%66 343
EDWARDS LIFESCIENCES CORPORATION-24.82%60 552